Federal

Federal Biosciences is a biotechnology company focused on developing next-generation microbial therapies to combat emerging infectious diseases and biothreats. The company leverages a proprietary platform to engineer beneficial microbes that can neutralize pathogens and bolster the human microbiome's natural defenses. Their approach combines synthetic biology with advanced microbial ecology to create precision therapeutics for indications where traditional antibiotics or vaccines may fall short. Federal Biosciences aims to provide scalable and rapidly deployable solutions for public health emergencies and chronic infectious conditions.